Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Acute myeloid leukaemia
Courtney D. DiNardo, Harry P. Erba, Sylvie D. Freeman, et al.
The Lancet (2023) Vol. 401, Iss. 10393, pp. 2073-2086
Open Access | Times Cited: 182

Showing 1-25 of 182 citing articles:

A 2024 Update on Menin Inhibitors. A New Class of Target Agents against KMT2A-Rearranged and NPM1-Mutated Acute Myeloid Leukemia
Anna Candoni, Gabriele Coppola
Hematology Reports (2024) Vol. 16, Iss. 2, pp. 244-254
Open Access | Times Cited: 21
Pathophysiology of Acute Myeloid Leukemia
Franziska Wachter, Yana Pikman
Acta Haematologica (2024) Vol. 147, Iss. 2, pp. 229-246
Closed Access | Times Cited: 16
Global, regional, and national burden of acute myeloid leukemia, 1990–2021: a systematic analysis for the global burden of disease study 2021
Yeming Zhou, Guiqin Huang, Xiaoya Cai, et al.
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 16
Clinico‐Genomic Interrogation of Secondary‐Type Acute Myeloid Leukemia: Response and Outcomes to Contemporary Therapies
Jayastu Senapati, Sanam Loghavi, Jennifer Marvin‐Peek, et al.
American Journal of Hematology (2025)
Closed Access | Times Cited: 2
Contemporary Management of Acute Myeloid Leukemia
Sangeetha Venugopal, Mikkael A. Sekeres
JAMA Oncology (2024) Vol. 10, Iss. 10, pp. 1417-1417
Closed Access | Times Cited: 13
CoHIT: a one-pot ultrasensitive ERA-CRISPR system for detecting multiple same-site indels
Yin Liu, Xinyi Liu, Dongyi Wei, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Bispecific Aptamer-Drug Conjugates Selectively Eliminate Malignant Hematologic Cells for Treating Acute Myeloid Leukemia
Xiaodong Li, Jiacheng Dai, Yuanyuan Shi, et al.
Langmuir (2025)
Closed Access | Times Cited: 1
Design, Synthesis and Biological Evaluation of Novel 9H Purine Derivatives as Potent CDK9 Inhibitors
Chunlei Tang, Dong Wang, Huabing Wang, et al.
Chemical Biology & Drug Design (2025) Vol. 105, Iss. 2
Closed Access | Times Cited: 1
IHCH9033, a novel class I HDAC inhibitor, synergizes with FLT3 inhibitor and rescues quizartinib resistance in FLT3-ITD AML via enhancing DNA damage response
Mingyue Yao, Wenzhong Yan, Wang Yf, et al.
Experimental Hematology and Oncology (2025) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Therapeutic horizon of acute myeloid leukemia: Success, optimism, and challenges
Jayastu Senapati, Tapan M. Kadia, Naval Daver, et al.
Cancer (2025) Vol. 131, Iss. 7
Closed Access | Times Cited: 1
Venetoclax with Hypomethylating Agents in Newly Diagnosed Acute Myeloid Leukemia: A Systematic Review and Meta-Analysis of Survival Data from Real-World Studies
Andrealuna Ucciero, F Pagnoni, Lorenza Scotti, et al.
Cancers (2023) Vol. 15, Iss. 18, pp. 4618-4618
Open Access | Times Cited: 20
Small extracellular vesicles derived from acute myeloid leukemia cells promote leukemogenesis by transferring miR-221-3p
Mengyu Li, Guohuan Sun, Jinlian Zhao, et al.
Haematologica (2024) Vol. 109, Iss. 10, pp. 3209-3221
Open Access | Times Cited: 7
Lower intensity therapy with cladribine/low dose cytarabine/venetoclax in older patients with acute myeloid leukemia compares favorably with intensive chemotherapy among patients undergoing allogeneic stem cell transplantation
Jayastu Senapati, Hagop M. Kantarjian, Alexandre Bazinet, et al.
Cancer (2024) Vol. 130, Iss. 19, pp. 3333-3343
Closed Access | Times Cited: 7
Aging and comprehensive molecular profiling in acute myeloid leukemia
Jianfeng Li, Wenyan Cheng, Xiangjie Lin, et al.
Proceedings of the National Academy of Sciences (2024) Vol. 121, Iss. 10
Open Access | Times Cited: 6
Age-specific survival in acute myeloid leukemia in the Nordic countries through a half century
Kari Hemminki, Frantisek Zitricky, Asta Försti, et al.
Blood Cancer Journal (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 6
Hydrophobic tagging of small molecules: an overview of the literature and future outlook
Yang Zhou, Fan Zhou, Shujing Xu, et al.
Expert Opinion on Drug Discovery (2024) Vol. 19, Iss. 7, pp. 799-813
Closed Access | Times Cited: 6
IL1RAP-specific T cell engager depletes acute myeloid leukemia stem cells
Yi Zhang, Miso Park, Lucy Ghoda, et al.
Journal of Hematology & Oncology (2024) Vol. 17, Iss. 1
Open Access | Times Cited: 6
Systemic Multifunctional Nanovaccines for Potent Personalized Immunotherapy of Acute Myeloid Leukemia
Peng Zhang, Tanzhen Wang, Guanhong Cui, et al.
Advanced Materials (2024)
Closed Access | Times Cited: 6
Risk Stratification in Older Intensively Treated Patients With AML
Jurjen Versluis, Marlen Metzner, Ariel Wang, et al.
Journal of Clinical Oncology (2024) Vol. 42, Iss. 34, pp. 4084-4094
Closed Access | Times Cited: 6
The ISTH DIC-score predicts early mortality in patients with non-promyelocitic acute myeloid leukemia
Giovangiacinto Paterno, Raffaele Palmieri, Cristiano Tesei, et al.
Thrombosis Research (2024) Vol. 236, pp. 30-36
Open Access | Times Cited: 5
Holotrichones A and B, potent anti-leukemic lindenane-type sesquiterpene trimers with unprecedented complex carbon skeletons from a rare Chloranthus species
Xuejiao Wang, Jun-Li Xin, Hong Xiang, et al.
Chinese Chemical Letters (2024) Vol. 35, Iss. 12, pp. 109682-109682
Closed Access | Times Cited: 5
Recent Advances in Material Technology for Leukemia Treatments
Feng Li, Huaiji Wang, Tong Ye, et al.
Advanced Materials (2024) Vol. 36, Iss. 26
Closed Access | Times Cited: 5
Advances in Drug Delivery Systems for the Treatment of Acute Myeloid Leukemia
Xia Wu, Fangfang Wang, Xijing Yang, et al.
Small (2024) Vol. 20, Iss. 42
Closed Access | Times Cited: 5
Genetic variations in DNA excision repair pathway contribute to the chemosensitivity and prognosis of acute myeloid leukemia
Amin Zhang, Wancheng Liu, Xiaodong Guo, et al.
Clinica Chimica Acta (2024) Vol. 558, pp. 117899-117899
Closed Access | Times Cited: 4
Higher TIGIT+ γδ TCM cells may predict poor prognosis in younger adult patients with non-acute promyelocytic AML
Qi Hou, Penglin Wang, Xueting Kong, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top